GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zenotech Laboratories Ltd (BOM:532039) » Definitions » EV-to-EBITDA

Zenotech Laboratories (BOM:532039) EV-to-EBITDA : 19.38 (As of Jun. 21, 2024)


View and export this data going back to 1996. Start your Free Trial

What is Zenotech Laboratories EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Zenotech Laboratories's enterprise value is ₹3,533.2 Mil. Zenotech Laboratories's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ₹182.3 Mil. Therefore, Zenotech Laboratories's EV-to-EBITDA for today is 19.38.

The historical rank and industry rank for Zenotech Laboratories's EV-to-EBITDA or its related term are showing as below:

BOM:532039' s EV-to-EBITDA Range Over the Past 10 Years
Min: -54.08   Med: -2.74   Max: 124.78
Current: 19.39

During the past 13 years, the highest EV-to-EBITDA of Zenotech Laboratories was 124.78. The lowest was -54.08. And the median was -2.74.

BOM:532039's EV-to-EBITDA is ranked worse than
66.9% of 710 companies
in the Drug Manufacturers industry
Industry Median: 14.265 vs BOM:532039: 19.39

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-21), Zenotech Laboratories's stock price is ₹61.38. Zenotech Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹1.360. Therefore, Zenotech Laboratories's PE Ratio for today is 45.13.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Zenotech Laboratories EV-to-EBITDA Historical Data

The historical data trend for Zenotech Laboratories's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zenotech Laboratories EV-to-EBITDA Chart

Zenotech Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.49 34.15 17.18 12.67 18.62

Zenotech Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.67 18.11 17.36 19.94 18.62

Competitive Comparison of Zenotech Laboratories's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Zenotech Laboratories's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zenotech Laboratories's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zenotech Laboratories's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Zenotech Laboratories's EV-to-EBITDA falls into.



Zenotech Laboratories EV-to-EBITDA Calculation

Zenotech Laboratories's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=3533.198/182.266
=19.38

Zenotech Laboratories's current Enterprise Value is ₹3,533.2 Mil.
Zenotech Laboratories's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹182.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zenotech Laboratories  (BOM:532039) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Zenotech Laboratories's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=61.38/1.360
=45.13

Zenotech Laboratories's share price for today is ₹61.38.
Zenotech Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1.360.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Zenotech Laboratories EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Zenotech Laboratories's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Zenotech Laboratories (BOM:532039) Business Description

Traded in Other Exchanges
N/A
Address
Survey No. 250-252, Turkapally Village, Shamirpet Mandal, RR District, Hyderabad, TG, IND, 500 078
Zenotech Laboratories Ltd is an India-based pharmaceutical company. It is a pharmaceutical specialty generic injectables company engaged in the area of manufacturing biotechnology products. The Company's injectables product portfolio primarily serves niche therapy areas like oncology and anesthesiology. It also manufactures products such as granulocyte-colony stimulating factor (GCSF) and Granulocyte-macrophage colony-stimulating factor (GMCSF). The company earns a vast majority of the revenue from the sale of its contract research and manufacturing services.

Zenotech Laboratories (BOM:532039) Headlines

No Headlines